Pharmacogenomics: The Secret Weapon Against COVID-19
PGxOne™ Plus is a comprehensive pharmacogenomics test that can help select appropriate medications for patients with pre-existing comorbidities (cardiovascular diseases, diabetes, chronic respiratory disease, and others), patients with high-risk genotypes, as well as helping select both medications proposed to treat COVID-19 and those involved with patient supportive care.
Pharmacogenomics Testing: A Proposed Tool to Achieve Better COVID-19 Outcome in Patients with Chronic Disease Who are Prescribed Medications
COVID-19 Associated Coagulopathies and the Medications with Pharmacogenomics Associations That Are Used to Mitigate Them
PGx Testing: A Proposed Tool to Reduce Morbidity and Mortality in Patients Prescribed Chloroquine and Hydroxychloroquine for COVID-19
RxVision™, Admera Health’s Clinical Decision Support System for Physicians
- Gain digital access to all patients’ PGxOne™ Plus results even without an EMR integration
- Easily navigate test results with dynamic searches, including by medication, therapeutic area, and drug interactions
- Securely and easily refer a patient’s report to another physician
Medication and Gene Association List:
FDA Drug Labeling Pharmacogenomic Biomarkers Table
FDA Drug Labeling Pharmacogenomic Biomarkers Table
*For physician use only*
Healthcare professionals may utilize a courtesy consultation with a pharmacogenomics expert, Monday through Friday 8 am to 6 pm EST by calling 
844-4ADMERA (844.423.6372), or by scheduling 
a call.
Sample Submission Guidelines – PGxOneTM Plus
The following video, produced by DNA Genotek, will review proper techniques for collecting a buccal or cheek swab sample for processing in our laboratory in three easy steps. This will reduce the need for resample and is critical to yield good test results.
Physician PGx Consultation Form
*For physician use only*
Please schedule your courtesy consultation above, and have the Physician PGx Consultation Form downloaded prior to your call.
